Aureus Asset Management, LLC Oncternal Therapeutics, Inc. Transaction History

Aureus Asset Management, LLC

  • $1.51 Billion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$4.59 - $9.04 $183,600 - $361,599
-40,000 Reduced 56.97%
30,211 $251,000
Q2 2019

Aug 14, 2019
BUY
$4.86 - $9.24 $341,225 - $648,749
70,211 New
70,211 $468,000

Others Institutions Holding ONCT

# of Institutions
3
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $29.4M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Aureus Asset Management, LLC Portfolio

Follow Aureus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email